Health & Science

From obscurity to a Nobel Prize nomination: Houston scientists acclaimed for their patent-free COVID-19 vaccine

Corbevax, a low-cost coronavirus vaccine created in Houston, could be a better weapon against COVID-19 by reaching the unvaccinated in poorer countries.

Maria Bottazzi replaces vials of the RBD-based SARS-CoV-2 vaccine into a freezer at the Tropical Medicine Lab at Texas Children’s Hospital Center for Vaccine Development in Houston on Oct. 5, 2021.

No patent means lower cost

"We need to see the data"

Flipping the script

Reaching the global population

Subscribe to Today in Houston

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

* required